This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Benzyl benzoate

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • benzyl benzoate is a traditional treatment for scabies - it is licensed for use in adults, children and babies for the treatment of scabies
  • there is minimal absorption of the emulsion following application to the skin
  • benzyl benzoate can be irritant, it requires up to 3 treatments, each one day apart, and the scabies mite may be resistant to it; it is considered as a third line treatment behind permethrin 5% cream and malathion 0.5% liquid
  • benzyl benzoate can cause irritation to the skin, eyes and mucosal surfaces and should be avoided in infants and children where alternative ascaracided are available
  • there is a lack of safety data concerning the use of benzyl benzoate in pregnancy; breast-feeding should be suspended after application of treatment, but may be restarted once the emulsion has been washed off the body (1)

The summary of product characteristics should be consulted before prescribing this drug.

Reference:

  1. Drugs and Therapeutics Bulletin (2002), 40 (6), 43-46.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.